Phagocytosis and Immune Regulation
Phagocytosis and Immune Regulation is a research topic within Immunology. Science Explorer counts 17k research works in it since 1950. 23.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the mechanisms and regulation of apoptotic cell clearance, including the role of CD47, phagocytosis, TAM receptors, efferocytosis, and the implications for cancer immunotherapy. It explores the involvement of various molecules and pathways in the recognition and removal of apoptotic cells by phagocytes, shedding light on potential therapeutic targets for immune-related diseases.
- CD47
- apoptotic cells
- phagocytosis
- immune regulation
- clearance mechanisms
- TAM receptors
- efferocytosis
- cancer immunotherapy
- phosphatidylserine
- macrophages
- Research works
- 17k fractional, since 1950
- In the world top 10%
- 4k per year above
- Top-10% rate
- 23.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +34% the tick is no change
Which countries lead Phagocytosis and Immune Regulation research?
By volume, China and the United States publish the most (1.3k and 990 works in 2022–2025).
By volume, 2022–2025
- 1 China 1.3k works
- 2 United States 990 works
- 3 Germany 149 works
- 4 Japan 133 works
- 5 United Kingdom 123 works
- 6 India 107 works
- 7 France 102 works
- 8 South Korea 89 works
- 9 Italy 79 works
- 10 Canada 76 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Phagocytosis and Immune Regulation research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Phagocytosis and Immune Regulation research, followed by University of North Carolina at Chapel Hill and Sun Yat-sen University.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 27 works
- 2 University of North Carolina at Chapel HillUnited States 25 works
- 3 Sun Yat-sen UniversityChina 25 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 24 works
- 5 Sichuan UniversityChina 19 works
- 6 Shanghai Jiao Tong UniversityChina 18 works
- 7 Zhejiang UniversityChina 15 works
- 8 Huazhong University of Science and TechnologyChina 15 works
- 9 University of PennsylvaniaUnited States 15 works
- 10 Nanjing Medical UniversityChina 14 works
Who are the leading researchers in Phagocytosis and Immune Regulation?
The most-cited researchers publishing on Phagocytosis and Immune Regulation include Alberto Ortíz, Guido Kroemer and Gordon B. Mills.
- 1 Alberto Ortíz Spain 5.9k citations
- 2 Guido Kroemer France 4.2k citations
- 3 Gordon B. Mills United States 3.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Phagocytosis and Immune Regulation research done?
The largest centres of Phagocytosis and Immune Regulation research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Bethesda and Houston.
Largest cities, 2022–2025
Where it is the local speciality
- BethesdaUS · 28.1 works6.1×
- HoustonUS · 44.6 works4.8×
Location quotient: how much more of its research is in Phagocytosis and Immune Regulation than the world average.
Where is the best place to study Phagocytosis and Immune Regulation?
Among universities, judged by research, Sun Yat-sen University, Chinese Academy of Medical Sciences & Peking Union Medical College and China Pharmaceutical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Sun Yat-sen UniversityChina | 66.0 | 44.6% | 4.1× | 25 | +112.0% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 63.1 | 36.6% | 6.7× | 24 | +66.0% |
| 3 | China Pharmaceutical UniversityChina | 62.4 | 41.4% | 14.7× | 12 | — |
| 4 | China Medical UniversityChina | 61.0 | 48.2% | 7.9× | 10 | +112.1% |
| 5 | Guangzhou Medical UniversityChina | 59.4 | 38.1% | 10.2× | 10 | — |
| 6 | Fudan UniversityChina | 55.2 | 42.0% | 2.9× | 12 | +249.0% |
| 7 | Wenzhou Medical UniversityChina | 52.6 | 37.7% | 6.3× | 8 | +212.5% |
| 8 | Nanjing Medical UniversityChina | 51.4 | 29.8% | 7.2× | 14 | +102.6% |
| 9 | Sichuan UniversityChina | 49.7 | 39.4% | 3.0× | 19 | +55.7% |
| 10 | Southern Medical UniversityChina | 49.4 | 41.5% | 6.6× | 9 | — |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Phagocytosis and Immune Regulation research growing?
Output in 2018–2022 was 34% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Phagocytosis and Immune Regulation.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.